And he may not have to ditch his current tech either, maybe a couple of tweaks? I still like our chances of BRN getting involved with him at some level in the future, even if the facts at hand point in the opposite direction.
At the moment 99.9% of the industry isn't using our tech (that we know of), the question is, what percentage of the industry is likely to in the future?
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-7833
-
-
- There are more pages in this discussion • 25,748 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $333.0M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 16.8¢ | $1.174M | 6.869M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 185137 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 920196 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 210000 | 0.180 |
1 | 106099 | 0.175 |
15 | 841489 | 0.170 |
57 | 1332034 | 0.165 |
68 | 1476729 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 6100 | 1 |
0.170 | 250000 | 2 |
0.175 | 781225 | 11 |
0.180 | 1494832 | 38 |
0.185 | 1319693 | 27 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online